Abstract
Introduction. Vortioxetine is an antidepressant that was approved by the FDA for the treatment of major depressive disorder. The aim of the work was to assess the efficacy and safety of vortioxetine in patients with depression.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
